Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Robin who wrote (3059)	6/12/1998 6:16:00 PM
From: Nick	Read Replies (2) \| Respond to of 5736

Robin: When is SPRX expected to submit their application to the FDA? What is the progress of their clinical trials? CCSI has all that behind them, and are now in the final stages of the deal, so at this point your argument about cash infusion is moot. If you can call SPRX's non-approved device real, then how can you doubt CCSI's approved device? If there is no market as ASSensio claims, then SPRX has no market either, right? Or is he saying that CCSI has no market, but SPRX does? The longs' posts committing to the deal today are just speculation. It will be done, and one day soon we will all be surprised with the announcement of the deal. I am not in a hurry for it's announcement. I want the right deal and not a hurried deal, although I must admit that ASSensio will speed things up. Nick